Technology

C5i realigns leadership to tap exponential growth opportunities of AI revolution

Published

1 year ago

December 5, 2024

Elevates Nitesh Jain to CEO, Ashwin Mittal to transition to Executive Chairman

LONDON, Dec. 5, 2024 /PRNewswire/ — C5i, a global leader in applied AI solutions, has announced a strategic leadership transition to position the company for exponential growth in the transformative AI era. Nitesh Jain has been appointed as Chief Executive Officer (CEO), succeeding co-founder and outgoing CEO Ashwin Mittal, who will now assume the role of Executive Chairman.

Nitesh Jain, a key driver of organizational transformation as C5i’s President and Chief Operating Officer, will now focus on scaling the business, institutionalizing governance, expanding the company’s world-class talent pool, deepening client relationships, and advancing the solution portfolio.

Ashwin Mittal, in his role as Executive Chairman, will concentrate on long-term strategy, mergers and acquisitions, innovation in AI, corporate social responsibility, and brand initiatives. “This dual focus enables us to combine the governance of a global enterprise with the innovation and agility of a disruptor. Nitesh will expertly navigate the company in a competitive environment while allowing me to focus on bringing more outside-in perspective and direction to the company,” said Mittal.

Nitesh Jain remarked, “It’s an honor to lead C5i at such a transformative time in the AI industry. With our exceptional teams and a track record of delivering agile growth and meaningful client outcomes, I look forward to building on our success and driving the next chapter of innovation and impact.”

This leadership evolution underscores C5i’s commitment to balancing the scale and rigor of a global enterprise with the agility needed to stay ahead in an AI landscape which is poised to deliver unprecedented value over the next decade.

As businesses rapidly shift from AI experimentation to large-scale enterprise adoption, C5i is at the forefront of enabling organizations to harness the full potential of AI technologies such as Generative AI, Predictive AI, Machine Vision, Synthetic Data, and Agentic AI. With 1,800 employees and plans to grow its workforce to 5,000 within the next four years, C5i is scaling at an industry-leading pace. The company was among the first to establish its own AI Labs seven years ago and has been pioneering Generative AI applications well before the release of tools like ChatGPT. Its recent acquisitions of Incivus and Analytic Edge demonstrate its commitment to strengthening capabilities and delivering cutting-edge solutions.

This leadership evolution positions C5i to harness the unparalleled opportunities of the AI revolution while staying true to its commitment to delivering business impact with speed, scale, and trust.

About C5i

C5i is a pure-play AI & Analytics provider that combines the power of human perspective with AI technology to deliver trustworthy intelligence to global corporations. The company drives value through a comprehensive solution set, integrating multifunctional teams that have technical and business domain expertise with a robust suite of products, solutions, and services tailored for various horizontal and industry-specific use cases. At the core, C5i’s focus is to deliver business impact at speed and scale by driving adoption of AI-assisted decision-making.

C5i caters to some of the world’s largest enterprises, including many Fortune 500 companies. The company’s clients include 5 of the top 7 companies in the world by market cap, 7 of the top 10 CPG companies in the world and 4 of the top 10 pharmaceutical companies in the world. C5i has been recognized by leading industry analysts like Gartner and Forrester for its Analytics and AI capabilities and proprietary AI-based solutions.

Media Contact:

Megha Chaudhry

Vice President

Global Head of Marketing & Alliance Management, C5i

E: megha.chaudhry@c5i.ai

Logo: https://mma.prnewswire.com/media/2414892/4710621/C5i_New_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/c5i-realigns-leadership-to-tap-exponential-growth-opportunities-of-ai-revolution-302323673.html

Technology

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Published

48 minutes ago

April 22, 2026

DALLAS, April 22, 2026 /PRNewswire/ — IGCS International, a CVE-certified SDVOSB and leading provider of mission support and MRO supplies to the U.S. Department of Defense and federal agencies, today announced that Lacks Enterprises has acquired an equity stake in the company.

The strategic investment combines IGCS’s expertise in government supply chain, logistics, and MRO solutions with Lacks Enterprises’ advanced manufacturing capabilities, including electroplating, injection molding, composites, and testing for aerospace and defense.

“IGCS has built a strong track record supporting the Department of Defense… Partnering with Lacks Enterprises allows us to integrate cutting-edge manufacturing innovation into our offerings,” said Russ Spears, President of IGCS International.

Media Contact: Russ Spears, 214-733-7278, russ@igcsintl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/igcs-international-announces-strategic-equity-investment-by-lacks-enterprises-302750824.html

SOURCE IGCS International

Technology

Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

Published

48 minutes ago

April 22, 2026

GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.

Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13759613. A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-2026-302750154.html

SOURCE Shoulder Innovations

Technology

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Published

48 minutes ago

April 22, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated